BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20854387)

  • 61. Changes in redox and endoplasmic reticulum homeostasis are related to congenital generalized lipodystrophy type 2.
    Craveiro Sarmento AS; Gomes Lima J; de Souza Timoteo AR; Galvão Ururahy MA; Antunes de Araújo A; Carvalho Vasconcelos R; Cândido Dantas VK; Fassarella Agnez-Lima L; Araújo de Melo Campos JT
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Apr; 1865(4):158610. PubMed ID: 31917334
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A very rare cause of acute pancreatitis: Berardinelli-Seip congenital lipodystrophy.
    İşlek A; Sayar E; Yılmaz A; Duman Ö; Artan R
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():216-9. PubMed ID: 25910311
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Autonomic modulation in patients with congenital generalized lipodystrophy (Berardinelli-Seip syndrome).
    Faria CA; Moraes RS; Sobral-Filho DC; Rego AG; Baracho MF; Egito ES; Brandão-Neto J
    Europace; 2009 Jun; 11(6):763-9. PubMed ID: 19376819
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Microarray analysis during adipogenesis identifies new genes altered by antiretroviral drugs.
    Pacenti M; Barzon L; Favaretto F; Fincati K; Romano S; Milan G; Vettor R; Palù G
    AIDS; 2006 Aug; 20(13):1691-705. PubMed ID: 16931933
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical classification and treatment of congenital and acquired lipodystrophy.
    Chan JL; Oral EA
    Endocr Pract; 2010; 16(2):310-23. PubMed ID: 20061300
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nurses' knowledge about Berardinelli-Seip Congenital Lipodystrophy.
    Cândido Dantas VK; Soares JDS; de Azevedo Medeiros LB; Craveiro Sarmento AS; Xavier Nobre TT; de Andrade FB; Gomes de Lima J; de Melo Campos JTA
    PLoS One; 2018; 13(6):e0197784. PubMed ID: 29864145
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Loss-of-function variants affecting the STAGA complex component SUPT7L cause a developmental disorder with generalized lipodystrophy.
    Kopp J; Koch LA; Lyubenova H; Küchler O; Holtgrewe M; Ivanov A; Dubourg C; Launay E; Brachs S; Mundlos S; Ehmke N; Seelow D; Fradin M; Kornak U; Fischer-Zirnsak B
    Hum Genet; 2024 May; 143(5):683-694. PubMed ID: 38592547
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Pathogenic genes and adipogenic differentiation transcription factor PPARγ associated with congenital lipodystrophic diabetes].
    Zhang X; Qin Y; Lin F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Aug; 36(8):844-847. PubMed ID: 31400143
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An incidental finding of striking muscular hypertrophy leading to a diagnosis of Berardinelli Seip Congenital Lipodystrophy.
    Hann G; Salam A; Kapila P
    Arch Dis Child; 2013 Dec; 98(12):933. PubMed ID: 24023365
    [No Abstract]   [Full Text] [Related]  

  • 70. A YOUNG ADULT WITH GENERALIZED LIPODYSTROPHY AND DIABETES MELLITUS (CASE REPORT).
    Çelo E; Kalari B; Toti F
    Georgian Med News; 2018 Apr; (277):27-31. PubMed ID: 29745909
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Metreleptin (Myalept): a leptin analog for generalized lipodystrophy.
    Med Lett Drugs Ther; 2015 Jan; 57(1460):13-4. PubMed ID: 25581107
    [No Abstract]   [Full Text] [Related]  

  • 72. Berardinelli-Seip lipodystrophy.
    Kobashi Y; Schoenbaum A; Hasserjian RP; Rosenthal DI
    Skeletal Radiol; 2007 Oct; 36(10):999-1003. PubMed ID: 17554536
    [TBL] [Abstract][Full Text] [Related]  

  • 73. RNA-seq of peripheral blood mononuclear cells of congenital generalized lipodystrophy type 2 patients.
    Huang YH; Su TC; Wang CH; Wong SL; Chien YH; Wang YT; Hwu WL; Lee NC
    Sci Data; 2021 Oct; 8(1):265. PubMed ID: 34645804
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acquired generalised lipodystrophy and type 1 diabetes mellitus in a child: a rare and implacable association.
    Kumar R; Pilania RK; Bhatia A; Dayal D
    BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30076164
    [TBL] [Abstract][Full Text] [Related]  

  • 75. First metreleptin treatment for generalized lipodystrophy in Turkey.
    Simsir IY; Yurekli BS; Saygili F; Altay C; Akinci B
    Diabetes Obes Metab; 2017 Feb; 19(2):299-301. PubMed ID: 27717125
    [No Abstract]   [Full Text] [Related]  

  • 76. Amenorrhea, ptosis and high insulin requirement in a young girl.
    Hari Kumar KV; Kumar S
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S151-3. PubMed ID: 26482962
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Child with Lipemic Sample: Berardinelli-Seip Congenital Lipodystrophy.
    -Ain QU; Sheikh W; Shahzad N
    J Coll Physicians Surg Pak; 2020 Feb; 30(2):225. PubMed ID: 32036838
    [No Abstract]   [Full Text] [Related]  

  • 78. Postmortem Findings in a Young Man With Congenital Generalized Lipodystrophy, Type 4 Due to CAVIN1 Mutations.
    Patni N; Vuitch F; Garg A
    J Clin Endocrinol Metab; 2019 Mar; 104(3):957-960. PubMed ID: 30476128
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Coronary arterial calcification in patients with congenital generalised lipodystrophy: A case series.
    Feijó BMXCRR; Mendonça RM; Egito EST; Lima DN; Campos JTAM; Lima JG
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):863-866. PubMed ID: 35864565
    [No Abstract]   [Full Text] [Related]  

  • 80. W(h)ither metreleptin for lipodystrophy and the metabolic syndrome?
    Mantzoros CS
    Endocr Pract; 2010; 16(2):162-6. PubMed ID: 20350904
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.